Table 2 Use of prophylaxis during observation period
From: Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions
All subjects (n = 220) | 18-39 years (n = 160) | ≥40 years (n = 60) | p value | |
|---|---|---|---|---|
Prophylaxis, No (%) | 155 (70) | 120 (75) | 35 (58) | 0.0202 |
Stable regimen | 103 (66) | 77 (64) | 26 (74) | NS |
Variable regimen: | 52 (34) | 43 (36) | 9 (26) | NS |
Started | 11 (21) | 8 (19) | 3* (33) | NS |
Changed | 41 (79) | 34 (79) | 7 (78) | NS |
Discontinued | 11 (21) | 7 (21) | 2 (22) | NS |
Type of prophylaxis 1 | ||||
Continuous | 144 (94) | 112 (94) | 32 (92) | NS |
Intermittent: | 10 (6) | 7 (6) | 3 (8) | NS |
Short-term | 3 (2) | 1 (1) | 2 (6) | |
Intermediate | 7 (5) | 6 (5) | 1 (3) |